<DOC>
	<DOCNO>NCT01131000</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy intravenous ibuprofen reduce fever 4 hour .</brief_summary>
	<brief_title>Efficacy , Safety , Pharmacokinetics Intravenous Ibuprofen Adult Febrile Patients</brief_title>
	<detailed_description>The primary objective study evaluate efficacy single 400 mg dose intravenous ibuprofen reduce fever great equal 101.0ºF ( 38.3ºC ) , compare efficacy parallel placebo treatment .</detailed_description>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Be hospitalize 2 . Have new ( chronic , within last 7 day ) onset fever , document temperature great equal 101.0ºF ( 38.3ºC ) 3 . Have adequate intravenous access 4 . Have ability understand requirement study , willing provide write informed consent ( evidenced signature inform consent document approve Institutional Review Board ) , agree abide study restriction return require assessment 1 . Be less 18 year age 2 . Have receive antipyretic drug therapy ( e.g. , aspirin , NSAIDs , acetaminophen ) within 4 hour dose 3 . Have history allergy hypersensitivity component IVIb , NSAIDs ( include aspirin ) , COX2 inhibitors 4 . Be pregnant nursing 5 . Have history severe head trauma require current hospitalization , intracranial surgery , stroke within previous 30 day , history intracerebral arteriovenous malformation , cerebral aneurysm , central nervous system mass lesion 6 . Weigh le 40 kg 7 . Have history congenital bleeding diatheses ( e.g. , hemophilia ) active clinically significant bleeding , underlie platelet dysfunction , include ( limited ) idiopathic thrombocytopenic purpura , disseminate intravascular coagulation , congenital platelet dysfunction 8 . Have gastrointestinal bleeding require medical intervention within previous 6 week ( unless definitive surgery perform ) 9 . Have platelet count le 30,000/mm3 10 . Be receive full dose anticoagulation therapy 11 . Have fever secondary blood drug reaction 12 . Have expect life span le 14 day imminent withdrawal life support severity illness 13 . Be receive treatment corticosteroid ( Patients expect receive corticosteroid Treatment Period Hour 120 Posttreatment Period eligible . ) 14 . Have neurogenic fever 15 . Be dialysis , oliguria creatinine great 3.0 mg/dL , receive nephrotoxic drug 16 . Have major surgery within past 12 hour , unless adequate hemostasis achieve 17 . Have receive another investigational drug within past 30 day 18 . Become afebrile ( temperature 101.0ºF [ 38.3ºC ] ) dose redevelop fever entry criterion hospitalization 19 . Be otherwise unsuitable study , opinion Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>